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Abstract
Background: The effect of population aging on future health services use depends on the relationship between
longevity gains and health. Whether further gains in life expectancy will be paired by improvements in health is
uncertain. We therefore analyze the effect of population ageing on health services use under different health
scenarios. We focus on the possibly diverging trends between different dimensions of health and their effect on
health services use.
Methods: Using longitudinal data on health and health services use, a latent Markov model has been estimated that
includes different dimensions of health. We use this model to perform a simulation study and analyze the health
dynamics that drive the effect of population aging. We simulate three health scenarios on the relationship between
longevity and health (expansion of morbidity, compression of morbidity, and the dynamic equilibrium scenario). We
use the scenarios to predict costs of health services use in the Netherlands between 2010 and 2050.
Results: Hospital use is predicted to decline after 2040, whereas long-term care will continue to rise up to 2050.
Considerable differences in expenditure growth rates between scenarios with the same life expectancy but different
trends in health are found. Compression of morbidity generally leads to the lowest growth. The effect of additional
life expectancy gains within the same health scenario is relatively small for hospital care, but considerable for
long-term care.
Conclusions: By comparing different health scenarios resulting in the same life expectancy, we show that health
improvements do contain costs when they decrease morbidity but not mortality. This suggests that investing in
healthy aging can contribute to containing health expenditure growth.
Keywords: Health expenditures, Scenario analysis, Aging, Health trends
Background
The influence of population aging on health services
use depends on the relationship between longevity and
health. Whether increases in life expectancy result in
higher health care costs depends on whether additional
life years are spent in good or poor health. Moreover,
use of different types of health services, such as hospital
care or long-term care (LTC), will be related to particular
aspects of health. However, most studies that project
future health spending either assume that the relationship
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between mortality and health is fixed, or consider only
one dimension of health. These studies thus ignore the
importance of the potentially diverging trends between
mortality and health, and between different dimensions
of health for the growth of health spending. In this
paper, we use scenario analysis to assess how the influ-
ence of longevity gains on health expenditure growth is
driven by the uncertain relationship between longevity
and health.
Empirical studies show diverging trends between differ-
ent dimensions of health. Most Western countries have
been experiencing longevity gains over the past decades
[1]. At the same time, the number of years spent with
chronic diseases seems to have been increasing [2]. In con-
trast, life years spent with disability seem to be declining
or stable [3]. In general, the relationship between further
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increasing life expectancy and trends in health seems to
depend strongly on the dimension of health under consid-
eration. Also, trends in health are surrounded by consid-
erable uncertainty: findings differ between countries and
studies, especially for disability [3, 4].
Despite the uncertainty regarding the relationship
between mortality and health, a substantial part of the
research on cost of aging treats this relationship as fixed.
In particular, the time to death literature uses proximity
to death as a measure for morbidity [5, 6]. This litera-
ture implicitly assumes that trends in health and mortality
coincide. In that case, longevity gains do not lead to
increases in health expenditures but merely to postpone-
ment of costs to later ages. These type of studies thus
ignore the possibility of longevity gains without improve-
ment in underlying health, which would most likely lead
to higher health spending.
Other studies do differentiate between mortality and
health, but focus on a single health indicator. A number
of studies include disability trends in predictions of health
services use and expenditures in the U.S. [7–9]. A simi-
lar study exists for the Netherlands [10]. Since trends in
dimensions of health diverge, the use of a single health
indicator does not suffice to capture all relevant dynam-
ics. This is especially relevant because different health
dimensions relate to different types of health services.
For instance, use of hospital care is strongly related to
chronic diseases, whereas LTC use is mostly related to
disability [11].
Goldman et al. do use a more diverse set of health
variables in their projections for the U.S. [12]. However,
they only consider scenarios in which improvements in
life expectancy are caused by improvements in health.
Again, the not unlikely scenario that life expectancy
changes can occur without an improvement of health
is not taken into account. The resulting differences in
health expenditures between their scenarios are there-
fore small. Policy-oriented studies, such as those by the
European Commission and the OECD [13, 14] do con-
sider to what extent different health scenarios influ-
ence the effect of life expectancy growth on health
spending. These studies generally lack explicit modelling
of the underlying relationship between longevity and
health.
In this study we directly model this relationship. The
model is based on a latent health variable that incor-
porates a large set of health indicators. In contrast to
other studies, we do not treat longevity as an out-
come of health improvements but instead consider dif-
ferent health scenarios resulting in the same increase
in life expectancy. We relate the scenarios to the three
most common hypotheses on the relationship between
mortality and health and to the empirical evidence on
trends in health. Our aim is to gain insight into the
health dynamics that drive the effect of aging on expen-
diture growth. We apply the model to health services
projections in the Netherlands between 2010 and 2050.
We focus on hospital care, home care and institutional
LTC.
Trends in health
The three most common hypotheses on the relationship
between longevity and health have been formulated in the
1980s [15]. In the expansion of mortality hypothesis, med-
ical progress is expected to lead to an increasing survival
of people in poor health [16, 17]. As a result, the num-
ber of years spent in poor health expands. Instead, the
compression of morbidity hypothesis expects that medi-
cal progress is mostly aimed at improvements in health,
resulting in fewer years spent in poor health [18]. Finally,
the dynamic equilibrium hypothesis assumes a tradeoff
between increasing prevalence and decreasing severity of
chronic diseases, resulting in a constant proportion of life
spent in poor health [19].
In most Western countries, life expectancy has
increased by about 30 years during the last century
[4]. Almost all studies foresee a further increase of life
expectancy in the coming decades, e.g. [1]. In the Nether-
lands, life expectancy at birth was 78.8 for men and 82.7
for women in 2010. A further, almost linear, increase is
predicted, resulting in a life expectancy at birth of 83.8 for
men and 88.1 for women by 2050 [20]. The forecast for
remaining life expectancy at 65 is 21.1 years for men and
24.6 years for women, compared to 16.7 and 20.1 years,
respectively, in 2006 [20].
The relationship between health and longevity depends
on the dimension of health under consideration. Here,
we discuss evidence on trends in chronic diseases, dis-
ability, and lifestyle. The prevalence of chronic diseases is
rising in most countries, because the survival of people
with one or more chronic diseases is growing [2, 4, 21].
The rising trend in chronic diseases might partly be
the result of improved medical treatments of some fatal
conditions that do not change the age-specific onset of
those conditions. In the Netherlands, a decline in life
expectancy without chronic diseases from 53 to 48 years
for men and 52 to 43 years for women between 1983 and
2007 due to an increase in chronic conditions has been
observed [22, 23].
Evidence on trends in functioning and disability is
mixed, sometimes even between different studies in the
same country. In the U.S., a number of studies have found
improvements in functioning and a decline of disability
in the 1980s and 1990s [3]. A study for twelve OECD
countries, specifically on severe disability, finds that five
countries, including the Netherlands, show a decline in
severe disability, but a same number of countries show
an increasing trend [24]. Another study reports evidence
Wouterse et al. BMC Health Services Research  (2015) 15:574 Page 3 of 14
for several countries that the expected number of years
spent with severe disability is declining or stable, while the
number of years spent with moderate disability is increas-
ing [21]. This trend is also observed for the Netherlands
[25]. A meta study using results from five Dutch surveys
also finds evidence for this trend, but shows mixed find-
ings between surveys [26]. It seems that severe disability is
strongly linked to the last phase of life, whereas mild dis-
ability is not [27–29], implying that an expansion of life
expectancy increases life years spent with mild disability,
but years spent with severe disability remain stable.
Lifestyle differences between cohorts show diverging
trends. Obesity rates in the U.S. have been increasing for
successively born cohorts, while trends in smoking behav-
ior are optimistic [3]. An important positive influence is
the rise in education level [3, 21]. In the Netherlands, an
increase in the prevalence of obesity and a slight decline
in smoking, especially for men, have also been observed
[22]. Higher prevalence of obesity, higher alcohol con-
sumption and lower physical activity of 55 to 64-years old
in 2002–2003 compared to 1992–1993 have been found in
the Netherlands [30].
Empirical findings do not decisively show which
hypothesis is right. Trends differ between health dimen-
sions. The findings on the trends in disability are mixed.
It is also unclear how the diverging trends in the lifestyle
of younger cohorts will affect the prevalence of chronic
diseases and disability in the future. To account for the
uncertainty surrounding the relationship betweenmortal-
ity and heath, we base our simulation study on all three
hypotheses.
Methods
Our aim is to make scenarios of future health and health
service use, including trends in different dimensions of
health. The challenge is to capture all relevant relation-
ships between different aspects of health, while at the
same time keeping the model parsimonious enough to be
used in a simulation exercise. For this purpose, we use a
latent Markov model that we have developed earlier [31].
In this model, the relationship between a set of health
indicators and health services is modeled through a sin-
gle discrete variable with four states (including death).
Annual transition probabilities between the states of this
latent health variable are also estimated. In order to obtain
projections of all relevant dimensions of health, only sim-
ulations of the latent variable have to be made. We first
discuss how the Latent Markov model is estimated, and
then show how we use this model to simulate different
health scenarios.
Data
The model is estimated on a combined dataset of lon-
gitudinal health survey data linked with registry data
on health services use. The health survey we use is
the Longitudinal Ageing Study Amsterdam (LASA) [32].
This is a study among older adults in the Netherlands.
The study started in 1992 with 3107 respondents and a
new cohort was added in 2002. We link this survey to
registry data on hospital use between 1995 and 2007,
and long term care use between 2004 and 2007. From
this data we create an estimation sample for the years
1995–2007. The sample is described more extensively in
Appendix A.2.
Seven indicators of health and disability are used in
the model, covering physical as well as mental aspects of
health. Self-perceived health is measured on a five point
scale. Physical functioning is measured by a self-reported
indicator as well as an objective indicator. The first indi-
cator consists of three items, each pertaining to a mobility
activity in daily life. The indicator is a total score, rang-
ing between 1 (no limitations) and 4 (limitations for all
activities) [33]. The second indicator is a performance test,
measuring the time it takes for the respondent to put
on and take off a cardigan. Limitations in daily activities
are measured with the Global Activity Limitation Indica-
tor (GALI) [34]. The presence of chronic diseases is also
self-reported. The mental aspects of health included in
the study are depressive symptoms and cognitive impair-
ments. For depressive symptoms the Center for Epidemi-
ological Studies Depression Scale (CES-D) is used [35].
Cognitive impairments are measured by the Mini Mental
States Examination (MMSE) [36].
The latent Markov model
We use a Latent Markov Model to describe the relation-
ship between health and health services use over time. The
model assumes that an individual’s health and his health
services use are determined by an underlying unobserved
health variable. The model estimates this latent variable
based on the joint distribution of the separate health indi-
cators as well as the distribution of health services use.
The latent variable has a fixed number of states. Changes
in latent health over the life course are modeled through
annual transitions between the states. These transitions
are modeled as aMarkov process. Estimation of the model
is described in Appendix A.1, and in more detail in [31].
In the specification of the model that we use for the sim-
ulations, the latent variable has four states: three health
states and death. An individual’s latent health state deter-
mines how likely he is to report a particular health out-
come (as measured by the seven indicators) as well as
his likelihood of health services use. For instance, some-
one in good latent health will have a higher probability
of reporting good self-perceived health than someone in
poor latent health. Figure 1 shows how the states of the
latent variable are related to the observed health indica-
tors. The figure shows the expected outcomes, which for
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Fig. 1 The relationship between the latent health variable and the observed health indicators. Expected values of the observed health indicators for
each latent health state. Values have been standardized to lie between 0 (best outcome) and 1 (worst outcome)
ease of comparison have been standardized to lie between
0 (best outcome) and 1 (worst outcome). State 1 is related
to good health for all indicators. State 2 is related to mod-
erate health: a high probability of having chronic diseases,
moderate probability of having disability, moderate self-
perceived health, and low probabilities of having cognitive
impairments or depression. State 3 is poor health with
a high probability of disability, cognitive impairments,
and depression. The probability of reporting poor self-
perceived health in state 3 is only slightly higher than in
state 2.
Figure 2 shows how the states of the latent variable are
related to costs of health services use. The figure shows
the expected costs of the three different types of health
services for men by age. All other covariates are set at
baseline levels. Up to age 85–90, good health is related
to lowest expected costs for all three types of services,
and poor health is related to highest costs. Differences
in expected costs between good and moderate health
are larger for hospital and home care use than for LTC.
At the highest ages, the poor health state is not always
associated with the highest expected costs. For instance,
at ages higher than 93, expected costs of home care
use are higher for men in moderate health than men in
poor health. These differences are related to substitution
between types of care or mortality differences between
states.
Scenario analysis
Using the latent Markov model, we can perform cohort
simulations for the period 2010–2050. We start with the
Dutch older population between 65 and 95 in base year
2010. The initial distribution over the health states of this
population is based on the age- and sex-specific distribu-
tion of health states in the LASA sample. Based on the
transition probabilities from the model, the health and
expenditure distribution for the 2010 cohorts can be cal-
culated consecutively for the following years. Each year,
a new cohort of 65-years old men and women is added.
The size of these new cohorts is obtained from population
projections of Statistics Netherlands [37].
There are two ways in which different health scenar-
ios can be implemented in the simulation model: First,
we can change the proportion of people in a particu-
lar health state (initial health profile), for new cohorts
of 65-years old. Such a change can be seen as a conse-
quence of health changes that materialize at younger ages,
before 65. Second, we can change the transition probabil-
ities between health states in the model. These changes
are related to effects of trends in heath that materialize
after 65. The idea of the scenario analysis is that we start
with a given life expectancy in 2050, and then consider
different health scenarios to get there. For example, a rise
in life expectancy can be achieved by lowering the age-
specific probabilities of transiting to poor health in favor
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Fig. 2 The relationship between the latent health variable and costs of health services use. The age curve of expected costs of health services use
(hospital care, home care, long term care) for men (with baseline characteristics) for each latent health state
of remaining in good health. Instead, the same rise can be
achieved by lowering the probability of dying from poor
health in favor of remaining in poor health.
The implementation of each scenario starts with the
given remaining life expectancy in 2050. For each health
scenario we select the transition probabilities that have
to be adjusted according to the scenario. In general, we
adjust these probabilities by a single proportional change
each year. For instance, we can choose to reduce the prob-
ability of dying (from all other states) by x % per year.
We can assume that the additional surviving individuals
remain in their current health state. Because we use a sin-
gle adjustment parameter x, the value of this parameter
can be determined numerically based on the desired life
expectancy in 2050. In some scenarios we change both the
initial health distribution at 65 and the transition matrix.
In those cases, we first set the change in the initial health
distribution to a level we consider adequate, and then
calculate the required change in transition rates.
Implementation
We set remaining life expectancy at 65 in 2050 at two
given values: the forecasted values of 21.1 for men and
24.6 for women [20], and the more optimistic values of
24.1 for men and 27.6 for women. By using two values we
can assess the effect of changes in life expectancy growth
as well as the influence of health on growth of health
services use.
We use three overarching scenarios, based on the
morbidity hypotheses described earlier. We divide these
into several sub scenarios. In the first scenario, we let
the life expectancy gain be the result of an overall
decrease in mortality rates. This scenario is in accordance
with the expansion of morbidity hypothesis. Changes
in lifestyle do not lead to an improvement in age spe-
cific health, and medical technology is mostly applied to
decrease mortality for individuals in poor health with-
out changing the age specific onset of diseases. We
implement this scenario by decreasing the probability
of dying in each health state by the same proportion.
As a result, the number of years spent in poor health
increases.
The second scenario relates to the compression of mor-
bidity hypothesis. Prevention and changes in lifestyle lead
to better population health. As a result, life expectancy
gains are paired with longer remaining lifetime spent
in good health. We implement this scenario by increas-
ing the probabilities of remaining in good or moderate
health, compared to worse health outcomes. In the third
scenario, we adhere to the dynamic equilibrium hypoth-
esis: life years spent with one or more chronic diseases
increase, whereas the number of life years spent with
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severe disability remains constant. The remaining lifetime
spent in moderate health, associated with chronic dis-
eases but only mild disability, is prolonged. The time spent
in poor health, associated with severe disability, is kept
constant. We implement this scenario by decreasing the
probabilities of going from good or moderate health to
poor health and death in favor of going to or remaining
in moderate health. To be able to set both the remain-
ing lifetime as well as the time spent in poor health, we
also decrease the probability of dying in poor health with
a separate growth rate.
For the first scenario, we keep the initial health pro-
file at 65 at its 2010 level. The scenario can thus be
modeled by only changing the transition probabilities.
For the other two scenarios, we model health changes
either solely through changes in the transition proba-
bilities, or by a combination of changes in the initial
health profile and changes in the transition probabili-
ties. In the combined specification of the compression
scenario, we let the proportion of individuals in good
health at 65 gradually go to 100 % in 2050. Remain-
ing annual decrease in transition probabilities needed
for the desired life expectancy can then be numeri-
cally determined. In the combined specification of the
dynamic equilibrium scenario, we let the initial propor-
tion of 65-years old in moderate health increase to 45 % in
2050.
We end up with eight sub scenarios: a modest and
extreme life expectancy version for each scenario, and for
the compression and dynamic equilibrium scenarios an
additional version of the modest life expectancy scenario,
where only transition probabilities are changed. Addition-
ally, we include a baseline scenario in which the initial
health profile and transition probabilities are kept at their
2010 values.
As an illustration of how the scenarios are implemented,
Table 1 shows the distribution of initial population health
at 65, and the transition matrix for men at 75, in 2050
in the different scenarios. Scenarios with only a change
in transition probabilities are indicated by an o, scenarios
with changes in the initial health state by +, and extreme
life expectancy scenarios by ++.
We present the effects of the different scenarios from
three perspectives. First, we take an individual per-
spective, and consider the differences in remaining life
expectancy and costs of health services use over remain-
ing lifetime at 65 in 2050. Second, we describe the cross
sectional age profile of population health. Third, we look
at the growth in aggregated health services use and expen-
ditures between 2010 and 2050.
Results
Remaining healthy life expectancies at 65 for men in 2050
are depicted in Fig. 3. In the baseline scenario, healthy life
Table 1 Initial population health at 65 and transition matrix at 75
for men in 2050, under different health scenarios
Population health for men at 65
Share in 2050
Scenario Good Moderate Poor Deceased
Baseline (1o, 1++, 2o, 3o) 0.66 0.27 0.06 0.00
Compression (2+, 2++) 0.99 0.01 0.00 0.00
Dynamic (3+, 3++) 0.51 0.44 0.05 0.00
Transition matrix for men at 75 in 2050
State at t State at t + 1
Good Moderate Poor Deceased
Baseline
Good 0.87 0.07 0.04 0.02
Moderate 0.00 0.87 0.10 0.03
Poor 0.00 0.04 0.81 0.15
1o Expansion of morbidity
Good 0.92 0.04 0.02 0.01
Poor 0.00 0.04 0.88 0.09
1++ Expansion of morbidity, high life exp.
Moderate 0.00 0.95 0.04 0.01
Poor 0.00 0.04 0.90 0.06
2o Compression of morbidity. Transition
Good 0.94 0.03 0.02 0.01
Moderate 0.00 0.94 0.05 0.01
Poor 0.00 0.04 0.81 0.15
2+ Compression of morbidity. Transition and initial
Good 0.93 0.04 0.02 0.01
Moderate 0.00 0.93 0.06 0.02
Poor 0.00 0.04 0.81 0.15
2++ Compression of morbidity, high life exp. Transition and initial
Good 0.96 0.02 0.01 0.01
Moderate 0.00 0.96 0.03 0.01
Poor 0.00 0.04 0.81 0.15
3o Dynamic equilibrium. Transition
Good 0.87 0.10 0.02 0.01
Moderate 0.00 0.94 0.05 0.01
Poor 0.00 0.04 0.84 0.12
3+ Dynamic equilibrium. Transition and initial
Good 0.87 0.10 0.02 0.01
Moderate 0.00 0.94 0.04 0.01
Poor 0.00 0.04 0.84 0.12
3++ Dynamic equilibrium, high life exp. Transition and initial
Good 0.87 0.11 0.01 0.01
Moderate 0.00 0.97 0.03 0.01
Poor 0.00 0.04 0.86 0.11
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Fig. 3 The expected remaining lifeyears and health expenditures spent in each health state for 65-years old for men under different scenarios. 1
expansion of morbidity, 2 compression of morbidity, 3 dynamic equilibrium. o indicates the scenarios without changes in the health of new cohorts
of 65-years old, + the scenarios including health changes at 65, and ++ scenarios with additional gains in life expectancy
expectancy is equal to that in 2010. In the other scenar-
ios, life expectancy is either 21.1 or 24.1. In the extension
of morbidity scenarios the proportion of remaining life
spent in each state is equal to the baseline scenario. As a
result, the absolute number of years spent in poor health
increases. The compression of morbidity scenarios show
an increase in the number of years spent in good and
moderate health. The compression scenario that includes
changes in initial health at 65 results in more number of
years spent in good health than the scenario that only
includes health changes after 65. In the dynamic equilibri-
ums scenarios time spent inmoderate health, with chronic
disease but only mild disability, increases. Time spent in
poor health remains constant. In the scenario without
changes in initial health, the time spent in good health is
equal to the baseline scenario. In the scenario including
changes at 65 the time spent in good health is shorter, due
to the increasing proportion of 65-years old in moderate
health.
Figure 3 also shows the individual expected costs of
health services use in each health state for men at 65
over remaining life in 2050, for hospital care, home
care, and institutional LTC separately. Remaining life-
time expenditures show some considerable differences
between scenarios, especially between the compression
of morbidity scenarios and the others. Hospital expendi-
tures are 23,000 Euros in the baseline scenario. Hospital
expenditures are 5000 Euros higher in expansion of mor-
bidity scenario and 7000 Euros higher in the extreme life
expectancy variant of this scenario. In the improvement
of health scenarios, hospital expenditures are slightly
higher than in the baseline scenario for the moderate
life expectancy variant without initial health changes,
whereas expenditures are lower in the other two variants
(about 20,000 Euros). Hospital expenditures range from
29,000 Euros to 32,000 Euros in the dynamic equilibrium
scenario.
Home care expenditures over remaining lifetime are
24,500 Euros in the baseline scenarios. Expenditures
are higher in all other scenarios. Of the other scenar-
ios, expenditures are lowest in the different versions of
the compression of morbidity scenario (27,000–30,000
Euros), and range from 36,000–46,000 Euros in the other
scenarios. Institutional LTC expenditures are again low-
est in the baseline scenario (36,000 Euros). In the other
scenarios, expenditures range from 55,000 Euros in the
compression scenario without initial health changes to
86,500 Euros in the extreme life expectancy variant of the
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expansion scenario. In contrast to hospital and home care,
the extreme versions of all scenarios result in higher life-
time LTC expenditures compared to other versions of the
same scenario.
Figure 4 shows the health composition of the older
population in 2010, and in 2050 for each scenario. All
scenarios show the well-known baby boom effect: the
broadest part of the pyramid moves upward over time.
The population pyramids in the expansion of morbidity
scenarios show the same form as in 2010, only broader.
The compression of morbidity scenarios show an increase
of the proportion of individuals in good health, mainly
at the younger ages at the bottom of the pyramid. The
dynamic equilibrium scenarios show an increase of the
number of people in moderate health (without severe dis-
ability), especially at the middle and top of the pyramid.
When we compare the scenarios where only the transition
probabilities are changed to the scenarios where the ini-
tial age profile is also changed, we can see that in the latter
a larger part of the health changes occurs at the bottom
of the population pyramid. The scenarios with the more
extreme raise in life expectancy have a larger number of
people at the top of the population pyramid.
The projections of health care expenditures over the
years 2010–2050 are depicted in Fig. 5. Of the scenar-
ios with the more conservative life expectancy prediction,
the dynamic equilibrium scenario including initial health
changes and the expansion of morbidity scenario result
in the highest hospital expenditures. The lower preva-
lence of disability in the dynamic equilibrium scenario
thus seems to matter little for hospital expenditures. The
compression of morbidity scenarios, where the preva-
lence of chronic diseases is lower, result in considerably
lower hospital expenditures. The large difference between
the compression scenario without improvement in initial
health at 65 and the same scenario with improvement in
initial health is also noteworthy. Hospital expenditures in
the extreme life expectancy variants of the expansion and
dynamic equilibrium scenarios are slightly above spend-
ing in the standard variants. In contrast, hospital spending
in the compression of morbidity scenario with higher life
expectancy is lower than in the other versions of this
scenario.
Whereas hospital expenditures decrease or stabilize
after 2040, home care and institutional LTC expendi-
tures rise over the whole time interval in all scenarios,
Fig. 4 Health composition of the population in 2010 and projection for 2050 under different scenarios. The number of people in each health state
per age group (women left, men right)
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Fig. 5 Predictions of expenditures between 2010 and 2050, for hospital care, home care, and long-term care, for each scenario
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except the baseline. Home care expenditures are high-
est in the dynamic equilibrium scenario with extreme
life expectancy, followed by the moderate life expectancy
variant of the expansion scenario and the dynamic equi-
librium scenario without changes in initial health. The
moderate life expectancy variants of the compression
of morbidity scenarios are related to lowest expendi-
tures. However, the scenario without changes in ini-
tial health surpasses the baseline scenario around 2043.
Again, additional life expectancy gains lead to higher
expenditures in the expansion and dynamic equilibrium
scenario.
Institutional LTC expenditures are highest in the mod-
erate life expectancy variant of the expansion of mor-
bidity scenario. The moderate life expectancy variants of
the dynamic equilibrium scenario are second and third,
but the difference with the expansion scenario is rela-
tively larger than for hospital and home care. Here, the
lower prevalence of disability in the dynamic equilib-
rium scenarios compared to the expansion of morbid-
ity scenarios does have a strong effect on expenditures.
Although expenditures in compression of morbidity sce-
narios are lowest, the difference with the other scenarios
is smaller than for hospital care. For institutional LTC,
additional life expectancy gains have a relatively large
impact on spending in the expansion and dynamic equi-
libriums scenarios. LTC expenditures in the extreme life
expectancy version of the compression of morbidity sce-
nario are lower than the other variants of this scenario,
but they seem likely to surpass these scenarios after 2050.
Not including the baseline scenario, the annual growth
rates of expenditures range from 0.88 to 1.98 for hospi-
tal care, 1.78 to 2.89 for home care, and 2.15 to 3.16 for
institutional LTC.
Discussion
We have analyzed the consequences of population aging
based on three health scenarios: an expansion of morbid-
ity, a compression of morbidity, and a dynamic equilib-
rium. The way the scenarios are implemented is extreme:
in each scenario, adjustment of the selected health param-
eters explains the total change in life expectancy. In reality,
it might be more likely that life expectancy gains are
a result of a mix of scenarios. Extreme scenarios have
the advantage of showing the boundaries of the effect of
health on health expenditures. We find that the compres-
sion of morbidity scenarios lead to the smallest growth in
expenditures. The dynamic equilibrium scenarios result in
equal or higher expenditures for hospital and home care
services as the expansion of morbidity scenarios, but LTC
spending is lower.
In contrast to other studies [12, 38], we find substan-
tial differences in lifetime expenditures between health
scenarios. This difference can be explained by the fact that
in these studies improvement of health always leads to
longer life. For scenarios where we have also assumed a life
extending effect of better health we find similar results.
In the extreme life expectancy version of the compres-
sion of morbidity scenario we assume that the additional
gain in longevity is the result of a further improvement
of health. This indeed provides the same tradeoff found
in earlier studies: lower costs per life year are offset by
an increase in the number of life years. The extreme life
expectancy version of the compression scenario results
in some savings in lifetime hospital expenditures com-
pared to the other versions, but these are compensated
by an increase in expected LTC use at older ages. Com-
parison between health scenarios resulting in the same
life expectancy show that health improvements do con-
tain costs when they decreasemorbidity but not mortality.
Grootjans- van Kampen et al. [39] come to a similar
conclusion in a study focusing on differences between
diseases: prevention of lethal diseases tends to increase
health care costs, while prevention of non-lethal diseases
can lead to savings.
The real growth rate of aggregated health care expendi-
tures in the Netherlands during the last decade has been
around 4.4 percent [40]. Our results confirm earlier find-
ings that aging and underlying health changes can only
explain a part of health care expenditure growth. The
growth rates for LTC and home care are somewhat higher
than reported in another Dutch study [10]. This differ-
ence can be attributed to the fact that we study a longer
time period. LTC volume projections by the Netherlands
Institute for Social Research [41] for 2010 to 2030 are
within the range of our scenario projections over the same
period.
The time trends in aggregated expenditures show sub-
stantial differences between health scenarios. Again, dif-
ferences are generally larger between health scenarios
with the same life expectancy than between versions of
the same health scenarios with different life expectancy.
Our findings, to some extent, support the conclusion of
the time to death literature that longevity gains do not
necessarily lead to expenditure increases. Such result is
in line with the finding that increasing life expectancy in
the U.S. by gradually moving American cohorts to the
better health status enjoyed by Western Europeans could
lead to substantial health care savings [42]. However, as
we have shown, cost containment can only be achieved
when increasing life expectancy is indeed a result of health
improvements.
An important limitation of our study is that we
do not consider other drivers of health expenditure
growth besides demographics and health. The focus of
our research is on the way in which different inter-
actions between morbidity and mortality affect health
spending, and not on identifying all relevant drivers
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of health spending. Researchers who want to include
other drivers, such as the development of new medi-
cal technologies, should be aware of interaction effects.
For instance, it seems that new medical technologies
lead to a stronger rise in health spending for peo-
ple in poor health than it does for people in better
health [43].
Three recommendations for policy makers can be
drawn from this study. First, based on the empirical lit-
erature we cannot expect a decrease in the prevalence
of chronic diseases among the older population in the
short run. In this respect, the more optimistic expen-
diture development of the compression scenario seems
unlikely to be realized. However, investing in lifestyle
changes at younger ages can pay off in the long run
through a decrease in chronic diseases among the future
old. In fact, comparison between the compression scenar-
ios with and without changes in health before 65 shows
that life expectancy gains due to health improvements at
younger ages lead to less expenditure growth than when
these same gains are solely due to health improvements
after 65.
Second, the fact that LTC costs are lower in the dynamic
equilibrium scenario than in the expansion of morbidity
scenario shows the potential for cost containment through
preventing disability. Given that prevention of chronic dis-
eases among older adults can be difficult in the short term,
policies focusing on the improvement of independence
of older adults with chronic disease could contain LTC
costs. Third, in all scenarios population aging leads to a
rise in health services use. Health improvement policies
thus have an important but also slightly limited role in
containing health care costs.
Conclusions
The effect of population aging, and especially longer
life, on health services use depends on trends in diverse
aspects of underlying health. In this study, we have
performed a scenario analysis based on three com-
mon hypotheses about this relationship, using a com-
bined measure of health. We find substantial differ-
ences in health expenditure growth between the most
optimistic and the most pessimistic health scenarios.
By comparing different health scenarios resulting in
the same life expectancy, we have shown that health
improvements do contain costs when they decrease
morbidity but not mortality. Scenarios in which the
prevalence of chronic diseases increases, but the dis-
abling effect of these diseases decreases (dynamic
equilibrium) lead to relatively high growth in hospi-
tal services use, but a relatively limited growth in
LTC use. The results suggest that investing in healthy
aging can contribute to containing health expenditure
growth.
Endnote
1The sample is randomly selected from municipal
records, and representative of the Dutch population
initially aged 55–85 years in terms of socio-geographic
distribution and distribution of population density. The
representativeness is maintained because the attrition is
largely due to mortality, which also occurs in the general
population.
Appendix A: Methods and data
A.1 Specification of the latent Markov model
The model that we use for our simulations is a Latent
Markov model. The model is based on an unobserved
(latent) discrete health variable that determines the prob-
ability distribution of a number of observed health indica-
tors as well as health expenditures over time. The model
consists of two components. First, a measurement com-
ponent defining the relationship between the value of
the latent variable and the observed health indicators
and health care expenditures at a particular time. Sec-
ond, a structural component, modeling individual changes
in the latent variable over time [44]. Let ηi,t be the
value of latent health variable η for individual i in year
t, where η is a discrete variable with M number of
states. The first part of the model describes how the
values of J different observed discrete health indicators
y1i,t , . . . , y
J
i,t , and health care costs ci,t depend on the value
of ηi,t . For each state m of η we define a separate con-
ditional probability distribution for each health indicator
j, P
(
y ji,t = k|ηi,t = m
)
, and a probability density function
for expenditures f
(
ci,t|ηi,t = m, xi,t
)
.
For the functional form of the conditional probabilities
of the observed health indicators we use a multinomial
logit specification. For the conditional density functions of
the costs we use a two-part model specification. The first
part is a logit, describing the probability that individual i
uses any health care in year t. The second part is a GLM
with a Gamma distribution, describing the distribution of
health care costs for individual i, conditional on the fact
that individual i uses health care in year t. The logits for
the observed health indicators do not include covariates.
The two-partmodels for the costs include sex, partner sta-
tus, age, education level, and calendar year dummies as
covariates. Thus, the relationship between the latent vari-
able and the distribution of health care costs depends on
these covariates.
The structural part of the model describes how the
latent health variable changes over time. For this purpose
we use a first-order Markov model with annual transitions
between states. The Markov assumption entails that the
state of η in year t only depends on the state of η in year
t−1.Wemodel P (ηi,t = m|ηi,t−1 = l; xi,t
)
using a separate
multinomial logit for each state l ∈ M of ηi,t−1.We include
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the same set of covariates as in the conditional cost model
except calendar year.
To estimate the model we have to choose the number
of states M of the latent variable. Given M, we can jointly
estimate both parts of the model by maximizing the like-
lihood of the observed combinations of health indicators
and health care costs over all periods of time t = 1, ..,T
and all individuals i,= 1, ..,N . Let’s define θ as a vec-
tor containing all parameters of the multinomial logits
and two-part models that have to be estimated. Then, the
likelihood for an individual i is
P
(
















= mt−1; xi,t−1; θ)
T∏
t=0





) = f (ci,t|xi,t , ηi,t = m
) ∏ J
j = 1 P(
y ji,t|ηi,t = m
)





is the initial state probability. The log-
likelihood over all individuals can be maximized using
the expectation maximization algorithm. The number of
states of the latent variable can be determined by com-
paring model fit between specifications. Death is defined
as a separate state.
A.2 Data
The Latent Markov model is estimated on Dutch data
on health and hospital expenditures over the period
1995–2007. Health indicators are obtained from the
Longitudinal Aging Study Amsterdam (LASA) and hos-
pital use is based on register data. The relationship
between the latent variable and LTC and home care
costs is estimated ex-post. For this we use another
register available for the years 2004–2007. The differ-
ent datasets are combined through (anonymized) link-
age to the Dutch Municipal Register (GBA) which con-
tains basic information on everyone enlisted in a Dutch
municipality.
The Longitudinal Ageing Study Amsterdam (LASA) is
an ongoing observational study on predictors and conse-
quences of changes in emotional, physical, cognitive and
social functioning in older adults. The study follows a
representative sample of older adults in the Netherlands
since 1992 1. Data has been collected on a broad num-
ber of health dimensions. Respondents are interviewed
every three years. The LASA sample consists of two
cohorts. The first cohort started with 3107 respondents
born between 1908 and 1937. In 2002, a new cohort was
added. This cohort consisted of 1002 respondent born
between 1938 and 1947.
Health services use was estimated using registry data
on hospital use and LTC use. For hospital use, The
Dutch Hospital Discharge Register (LMR) was used: a
register of hospital admissions, providing nearly com-
plete coverage of hospital inpatient treatments. The Reg-
ister of the Administrative Office Exceptional Medical
Expenses (CAK) contains records on all use of institu-
tional LTC and formal home care in the Netherlands
covered by the Exceptional Medical Expenses Act
(AWBZ). Data from the LASA survey were linked with
these registries at Statistics Netherlands. Linkage of
data was available for the years 1995–2007 for the
LMR and for the years 2004–2007 for the LTC data.
Costs were calculated using the Dutch Costs of Illness
Study [45, 46].
Table 2 describes the estimation sample resulting from
linking the LASA survey to the health care data. Hos-
pital costs are observed ever year, while health data is
only observed once every three years or in case of death.
The information on annual hospital costs in the years for
which no survey data is available is included in the estima-
tion of the model. For the years without health survey data
gm(ci,t , yi,t|xi,t) in Eq. (1) is replaced by f (ci,t|xi,t , ηi,t = m)
as explained by [31].
Table 2 Number of observations per year in the estimation
sample. The sample consists of administrative hospital data
(available each year) and survey data on health indicators
(available once every three years)
Year LASA wave No. Obs With health*
1995 C 3414 547
1996 C 3437 1626
1997 3313 117
1998 D 3192 660
1999 D 3081 1351
2000 2967 99
2001 E 2873 617
2002 E/2B* 2762 1493
2003 2B 2634 500
2004 2533 99
2005 F 2428 630
2006 F 2336 1346
2007 2228 117
*Observations for which reported health indicators are available (reported in LASA
or deceased in that particular year)
*2B refers to the new LASA cohort introduced in 2002. In wave F the two cohorts
were combined
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